Mia D. Eriksson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mia D. Eriksson has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Johan Gunnar Eriksson
Department of General Practice and Primary Health Care, University of Helsinki, Helsinki, Finland
6 shared publications - Hannu Kautiainen
Primary Health Care Unit, Kuopio University Hospital, Kuopio, Finland
5 shared publications - Merja Kristiina Laine
Department of General Practice and Primary Health Care, University of Helsinki and Helsinki University Hospital
5 shared publications Minna K. Salonen
Folkhälsan Research Center Helsinki Finland
5 shared publicationsEero Kajantie
Department of Public Health Solutions, Public Health Promotion Unit, Finnish Institute for Health and Welfare, Helsinki, Finland
3 shared publicationsNiko Wasenius
Folkhälsans Forskningscentrum
3 shared publications
Latest Publications
- Open Access
- 19 December 2025
- Published by Elsevier in Primary Care Diabetes
- Vol. 20 (1) , 127-132
Mortality in offspring of women with type 1 diabetes during pregnancy
- 19 December 2025
- Published by Elsevier in Primary Care Diabetes
- Vol. 20 (1) , 127-132
Open AccessMortality in offspring of women with type 1 diabetes during pregnancy
- Open Access
- 1 November 2022
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 147 (2) , 175-185
Depressive symptoms and mortality‐findings from Helsinki birth cohort study
Background: Individuals with depression and depressive symptoms have a higher mortality rate than non‐depressed individuals. The increased comorbidity and mortality associated with depression has remained largely unexplained. The underlying pathophysiological differences between depressive subtypes, melancholic and non‐melancholic, may provide some explanation to this phenomenon.Methods: One thousand nine hundred and ninety five participants (mean age 61 years) from the Helsinki Birth Cohort Study were recruited for this prospective study and followed up for a mean of 14.1 years. Information regarding medical history, lifestyle, and biochemical parameters were obtained. Depressive symptoms were assessed using the Beck Depression Inventory. Standardized mortality ratios were calculated.Results: Participants were followed up for a total of 28,044 person‐years. The melancholic depressive group had an increased adjusted risk of mortality [HR 1.49 (95% CI: 1.02–2.20)] when compared to the non‐depressive group. Comparing mortality to the whole population of Finland using standardized mortality ratios (SMR) both the non‐melancholic [1.11 (95% CI: 0.85–1.44)] and melancholic depressive [1.26 (95% CI: 0.87–1.81)] groups had higher mortality than the non‐depressive group [0.82 (95% CI: 0.73–0.93)].Conclusions: Melancholic depressive symptoms are most strongly related to a higher mortality risk.
- 1 November 2022
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 147 (2) , 175-185
Open AccessDepressive symptoms and mortality‐findings from Helsinki birth cohort study
Background: Individuals with depression and depressive symptoms have a higher mortality rate than non‐depressed individuals. The increased comorbidity and mortality associated with depression has remained largely unexplained. The underlying pathophysiological differences between depressive subtypes, melancholic and non‐melancholic, may provide some explanation to this phenomenon.Methods: One thousand nine hundred and ninety five participants (mean age 61 years) from the Helsinki Birth Cohort Study were recruited for this prospective study and followed up for a mean of 14.1 years. Information regarding medical history, lifestyle, and biochemical parameters were obtained. Depressive symptoms were assessed using the Beck Depression Inventory. Standardized mortality ratios were calculated.Results: Participants were followed up for a total of 28,044 person‐years. The melancholic depressive group had an increased adjusted risk of mortality [HR 1.49 (95% CI: 1.02–2.20)] when compared to the non‐depressive group. Comparing mortality to the whole population of Finland using standardized mortality ratios (SMR) both the non‐melancholic [1.11 (95% CI: 0.85–1.44)] and melancholic depressive [1.26 (95% CI: 0.87–1.81)] groups had higher mortality than the non‐depressive group [0.82 (95% CI: 0.73–0.93)].Conclusions: Melancholic depressive symptoms are most strongly related to a higher mortality risk.
- Open Access
- 6 September 2022
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 21 (1) , 1-8
Higher pulse wave velocity in young adult offspring of mothers with type 1 diabetes: a case–control study
Background: Offspring of mothers with type 1 diabetes have an increased risk for acquiring early onset cardiovascular disease (CVD). Arterial stiffness, measured as pulse wave velocity (PWV), is a non-invasive biomarker for CVD risk assessment. Our aim is to determine whether PWV is increased in young adult offspring of mothers with type 1 diabetes. Methods: This is a case–control study carried out in the hospital district of Helsinki and Uusimaa, Finland. 75 offspring of mothers with type 1 diabetes (cases) and 84 offspring of mothers without diabetes (controls), aged 18–23 years, were enrolled in this study. All participants attended clinical assessments, including questionnaires and laboratory tests. Carotid-femoral PWV (cfPWV), carotid-radial PWV (crPWV), and PWV ratio were measured from each participant using the Complior Analyse mechanotransducer (Alam Medical, France). Student’s t-test and chi-squared test were used to assess differences between the groups. Stata 17.0, StataCorp LP (College Station, TX, USA) statistical package was used for the analysis. Results: We did not observe any differences in conventional CVD risk factors: systolic blood pressure, LDL, HbA1c, and smoking between cases and controls. We detected higher cfPWV in cases 6.5 (SD ± 1.2) m/s than in controls 6.2 (SD ± 0.7) m/s, p = 0.049, after adjustments for BMI, smoking, mean arterial pressure, height, and pulse rate was made. We did not observe any difference between cases and controls regarding crPWV or PWV ratio. Additionally, we detected no sex differences. Conclusions: We report a novel finding of signs of increased arterial stiffness already in young adult offspring of mothers with type 1 diabetes compared to matched offspring of mothers without diabetes. Our finding suggests that exposure to an adverse intrauterine environment of type 1 diabetes mothers may affect the vascular health of offspring already in young adulthood. Additional research within this topic is warranted.
- 6 September 2022
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 21 (1) , 1-8
Open AccessHigher pulse wave velocity in young adult offspring of mothers with type 1 diabetes: a case–control study
Background: Offspring of mothers with type 1 diabetes have an increased risk for acquiring early onset cardiovascular disease (CVD). Arterial stiffness, measured as pulse wave velocity (PWV), is a non-invasive biomarker for CVD risk assessment. Our aim is to determine whether PWV is increased in young adult offspring of mothers with type 1 diabetes. Methods: This is a case–control study carried out in the hospital district of Helsinki and Uusimaa, Finland. 75 offspring of mothers with type 1 diabetes (cases) and 84 offspring of mothers without diabetes (controls), aged 18–23 years, were enrolled in this study. All participants attended clinical assessments, including questionnaires and laboratory tests. Carotid-femoral PWV (cfPWV), carotid-radial PWV (crPWV), and PWV ratio were measured from each participant using the Complior Analyse mechanotransducer (Alam Medical, France). Student’s t-test and chi-squared test were used to assess differences between the groups. Stata 17.0, StataCorp LP (College Station, TX, USA) statistical package was used for the analysis. Results: We did not observe any differences in conventional CVD risk factors: systolic blood pressure, LDL, HbA1c, and smoking between cases and controls. We detected higher cfPWV in cases 6.5 (SD ± 1.2) m/s than in controls 6.2 (SD ± 0.7) m/s, p = 0.049, after adjustments for BMI, smoking, mean arterial pressure, height, and pulse rate was made. We did not observe any difference between cases and controls regarding crPWV or PWV ratio. Additionally, we detected no sex differences. Conclusions: We report a novel finding of signs of increased arterial stiffness already in young adult offspring of mothers with type 1 diabetes compared to matched offspring of mothers without diabetes. Our finding suggests that exposure to an adverse intrauterine environment of type 1 diabetes mothers may affect the vascular health of offspring already in young adulthood. Additional research within this topic is warranted.
- Open Access
- 28 April 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-11
Non-melancholic depressive symptoms are associated with above average fat mass index in the Helsinki birth cohort study
There is an existing link between two of the most common diseases, obesity and depression. These are both of great public health concern, but little is known about the relationships between the subtypes of these conditions. We hypothesized that non-melancholic depressive symptoms have a stronger relationship with both body composition (lean mass and fat mass) and dysfunctional glucose metabolism than melancholic depression. For this cross-sectional study 1510 participants from the Helsinki Birth Cohort Study had their body composition evaluated as lean mass and fat mass (Lean Mass Index [LMI, kg/m2] + Fat Mass Index [FMI kg/m2] = Body Mass Index). Participants were evaluated for depressive symptoms utilizing the Beck depression inventory, and had laboratory assessments including an oral glucose tolerance test. Higher than average FMI was associated with a higher percentage (mean [%], 95% CI) of participants scoring in the depressive range of the Beck depression inventory (20.2, 17.2–23.2) compared to those with low FMI (16.3, 13.8–18.9; p = 0.048) when adjusted for age, sex, education, and fasting plasma glucose concentration. Higher FMI was associated with a higher likelihood of having depressive symptoms (OR per 1-SD FMI = 1.37, 95% CI 1.13–1.65), whereas higher LMI was associated with a lower likelihood of having depressive symptoms (OR per 1-SD LMI = 0.76, 95% CI 0.64–0.91). Participants with an above average FMI more frequently (mean [%], 95% CI) had non-melancholic depressive symptoms (14.7, 11.8–17.7) as compared to those with low FMI (9.7, 7.6–11.9; p = 0.008) regardless of LMI levels. There was no difference between the body composition groups in the likelihood of having melancholic depressive symptoms. The non-melancholic group had higher (mean [kg/m2], SD) FMI (9.6, 4.1) than either of the other groups (BDI < 10: 7.7, 3.1; melancholic: 7.9, 3.6; p < 0.001), and a higher (mean [mmol/l], SD) 2-h glucose concentration (7.21, 1.65) than the non-depressed group (6.71, 1.70; p = 0.005). As hypothesized, non-melancholic depressive symptoms are most closely related to high fat mass index and dysfunctional glucose metabolism.
- 28 April 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-11
Open AccessNon-melancholic depressive symptoms are associated with above average fat mass index in the Helsinki birth cohort study
There is an existing link between two of the most common diseases, obesity and depression. These are both of great public health concern, but little is known about the relationships between the subtypes of these conditions. We hypothesized that non-melancholic depressive symptoms have a stronger relationship with both body composition (lean mass and fat mass) and dysfunctional glucose metabolism than melancholic depression. For this cross-sectional study 1510 participants from the Helsinki Birth Cohort Study had their body composition evaluated as lean mass and fat mass (Lean Mass Index [LMI, kg/m2] + Fat Mass Index [FMI kg/m2] = Body Mass Index). Participants were evaluated for depressive symptoms utilizing the Beck depression inventory, and had laboratory assessments including an oral glucose tolerance test. Higher than average FMI was associated with a higher percentage (mean [%], 95% CI) of participants scoring in the depressive range of the Beck depression inventory (20.2, 17.2–23.2) compared to those with low FMI (16.3, 13.8–18.9; p = 0.048) when adjusted for age, sex, education, and fasting plasma glucose concentration. Higher FMI was associated with a higher likelihood of having depressive symptoms (OR per 1-SD FMI = 1.37, 95% CI 1.13–1.65), whereas higher LMI was associated with a lower likelihood of having depressive symptoms (OR per 1-SD LMI = 0.76, 95% CI 0.64–0.91). Participants with an above average FMI more frequently (mean [%], 95% CI) had non-melancholic depressive symptoms (14.7, 11.8–17.7) as compared to those with low FMI (9.7, 7.6–11.9; p = 0.008) regardless of LMI levels. There was no difference between the body composition groups in the likelihood of having melancholic depressive symptoms. The non-melancholic group had higher (mean [kg/m2], SD) FMI (9.6, 4.1) than either of the other groups (BDI < 10: 7.7, 3.1; melancholic: 7.9, 3.6; p < 0.001), and a higher (mean [mmol/l], SD) 2-h glucose concentration (7.21, 1.65) than the non-depressed group (6.71, 1.70; p = 0.005). As hypothesized, non-melancholic depressive symptoms are most closely related to high fat mass index and dysfunctional glucose metabolism.
- Open Access
- 21 September 2021
- Published by Springer Nature in Research Square
The Relationship Between Body Composition, Glucose Metabolism, and Subtypes of Depressive Symptoms – Findings From the Helsinki Birth Cohort Study
Background There is an existing link between two of the most common diseases, obesity and depression. These are both of great public health concern, but little is known about the relationships between the subtypes of these conditions. We hypothesized that non-melancholic depressive symptoms have a stronger relationship with both body composition (lean mass and fat mass) and dysfunctional glucose metabolism than melancholic depression. Methods For this cross-sectional study 1 510 participants from the Helsinki Birth Cohort Study had their body composition evaluated as lean mass and fat mass (Lean Mass Index + Fat Mass Index = Body Mass Index). Participants were evaluated for depressive symptoms utilizing the Beck Depression Inventory, and had laboratory assessments including an oral glucose tolerance test. Results Higher than average Fat Mass Index (kg/m2) was associated with a higher percentage of participants scoring in the depressive range of the Beck Depression Inventory (p=0.048). Higher Fat Mass Index was associated with a higher likelihood of having depressive symptoms (OR per 1-SD Fat Mass Index=1.37, 95% CI: 1.13-1.65), whereas higher Lean Mass Index (kg/m2) was associated with a lower likelihood of having depressive symptoms (OR per 1-SD Lean Mass Index=0.76, 95% CI: 0.64-0.91). Participants with an above average Fat Mass Index more frequently had non-melancholic depressive symptoms (p=0.008) regardless of Lean Mass Index levels (p=0.38). There was no difference between the body composition groups in the likelihood of having melancholic depressive symptoms (Fat Mass Index p=0.83, Lean Mass Index p=0.93). The non-melancholic group had higher Fat Mass Index than either of the other groups (pConclusion As hypothesized, non-melancholic depressive symptoms are most closely related to high fat mass index and dysfunctional glucose metabolism.
- 21 September 2021
- Published by Springer Nature in Research Square
Open AccessThe Relationship Between Body Composition, Glucose Metabolism, and Subtypes of Depressive Symptoms – Findings From the Helsinki Birth Cohort Study
Background There is an existing link between two of the most common diseases, obesity and depression. These are both of great public health concern, but little is known about the relationships between the subtypes of these conditions. We hypothesized that non-melancholic depressive symptoms have a stronger relationship with both body composition (lean mass and fat mass) and dysfunctional glucose metabolism than melancholic depression. Methods For this cross-sectional study 1 510 participants from the Helsinki Birth Cohort Study had their body composition evaluated as lean mass and fat mass (Lean Mass Index + Fat Mass Index = Body Mass Index). Participants were evaluated for depressive symptoms utilizing the Beck Depression Inventory, and had laboratory assessments including an oral glucose tolerance test. Results Higher than average Fat Mass Index (kg/m2) was associated with a higher percentage of participants scoring in the depressive range of the Beck Depression Inventory (p=0.048). Higher Fat Mass Index was associated with a higher likelihood of having depressive symptoms (OR per 1-SD Fat Mass Index=1.37, 95% CI: 1.13-1.65), whereas higher Lean Mass Index (kg/m2) was associated with a lower likelihood of having depressive symptoms (OR per 1-SD Lean Mass Index=0.76, 95% CI: 0.64-0.91). Participants with an above average Fat Mass Index more frequently had non-melancholic depressive symptoms (p=0.008) regardless of Lean Mass Index levels (p=0.38). There was no difference between the body composition groups in the likelihood of having melancholic depressive symptoms (Fat Mass Index p=0.83, Lean Mass Index p=0.93). The non-melancholic group had higher Fat Mass Index than either of the other groups (pConclusion As hypothesized, non-melancholic depressive symptoms are most closely related to high fat mass index and dysfunctional glucose metabolism.
- Open Access
- 1 June 2021
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 145, 110488
Advanced glycation end products measured by skin autofluorescence are associated with melancholic depressive symptoms – Findings from Helsinki Birth Cohort Study
- 1 June 2021
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 145, 110488
Open AccessAdvanced glycation end products measured by skin autofluorescence are associated with melancholic depressive symptoms – Findings from Helsinki Birth Cohort Study
- Open Access
- 1 January 2021
- Published by Taylor & Francis in Annals of Medicine
- Vol. 53 (1) , 531-540
Higher carotid-radial pulse wave velocity is associated with non-melancholic depressive symptoms in men – findings from Helsinki Birth Cohort Study
Depression and cardiovascular disease (CVD) are major causes of global disease burden that are interrelated through mostly unknown mechanisms. We studied the relationship of melancholic and non-mel...
- 1 January 2021
- Published by Taylor & Francis in Annals of Medicine
- Vol. 53 (1) , 531-540
Open AccessHigher carotid-radial pulse wave velocity is associated with non-melancholic depressive symptoms in men – findings from Helsinki Birth Cohort Study
Depression and cardiovascular disease (CVD) are major causes of global disease burden that are interrelated through mostly unknown mechanisms. We studied the relationship of melancholic and non-mel...
- 1 January 2020
- Published by Elsevier in Behavioural Brain Research
- Vol. 378, 112303
Intraventricular murine Aβ infusion elicits hippocampal inflammation and disrupts the consolidation, but not retrieval, of conditioned fear in C57BL6/J mice
- 1 January 2020
- Published by Elsevier in Behavioural Brain Research
- Vol. 378, 112303
Intraventricular murine Aβ infusion elicits hippocampal inflammation and disrupts the consolidation, but not retrieval, of conditioned fear in C57BL6/J mice
- 26 December 2013
- Published by Wiley in American Journal of Human Biology
- Vol. 26 (2) , 111-116
Early life stress and later health outcomes—findings from the Helsinki Birth Cohort Study
Objectives: Severe early life stress (ELS) is a well‐known risk factor for mental health disorders later in life. Not only mental health disorders are affected by ELS but early life stressors can also induce physical and biological changes increasing the risk for several noncommunicable diseases including type 2 diabetes and cardiovascular disease.Methods: This review focuses on the cohesive studies of individuals from the Helsinki Birth Cohort Study born 1934–1944 who were sent abroad from Finland during World War II as “war children.”Results: The review encompasses both epidemiological and clinical studies ranging from mental health disorders to type 2 diabetes and cardiovascular disease as well as potential underlying mechanisms explaining the association between ELS and later health.Conclusions: ELS is capable of causing changes that alter the normal physiological responses and thereby increase later disease risk, including cardiometabolic disorders. Am. J. Hum. Biol. 26:111–116, 2014.
- 26 December 2013
- Published by Wiley in American Journal of Human Biology
- Vol. 26 (2) , 111-116
Early life stress and later health outcomes—findings from the Helsinki Birth Cohort Study
Objectives: Severe early life stress (ELS) is a well‐known risk factor for mental health disorders later in life. Not only mental health disorders are affected by ELS but early life stressors can also induce physical and biological changes increasing the risk for several noncommunicable diseases including type 2 diabetes and cardiovascular disease.Methods: This review focuses on the cohesive studies of individuals from the Helsinki Birth Cohort Study born 1934–1944 who were sent abroad from Finland during World War II as “war children.”Results: The review encompasses both epidemiological and clinical studies ranging from mental health disorders to type 2 diabetes and cardiovascular disease as well as potential underlying mechanisms explaining the association between ELS and later health.Conclusions: ELS is capable of causing changes that alter the normal physiological responses and thereby increase later disease risk, including cardiometabolic disorders. Am. J. Hum. Biol. 26:111–116, 2014.